No significant association between the TP53 codon 72 polymorphism and breast cancer risk: A meta-analysis of 21 studies involving 24,063 subjects

Breast Cancer Research and Treatment

Volumn 125, Issue 1, 2011, Pages 201-205

  Ma, Yanlei ^a   Yang, Jianjun ^a   Liu, Zhihua ^a   Zhang, Peng ^a   Yang, Zhe ^a   Wang, Yu ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Polymorphism; TP53 codon 72

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; EMBASE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INHERITANCE; KNOWLEDGE BASE; MAJOR CLINICAL STUDY; MEDLINE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; LINEAR MODELS; ODDS RATIO; PEDIGREE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78651078681     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0920-1     Document Type: Article

References (33)

1. EM Berns IL van Staveren MP Look M Smid JGM Klijn JA Foekens 1998 Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer Br J Cancer 77 1130 1136 1:CAS:528: DyaK1cXisVKhs7o%3D 9569050
2. Goldhirsch A (2000) Breast cancer. In: Cavalli F, Hansen H, Kaye SB (eds) Textbook of medical oncology. Martin Dunitz, London, pp 137-183
3. JM Nigro SJ Baker AC Preisinger JM Jessup R Hostetter K Cleary SH Bigner N Davidson S Baylin P Devilee, et al. 1989 Mutations in the p53 gene occur in diverse human tumour types Nature 342 705 708 1:CAS:528:DyaK3cXkvFyhug%3D%3D 10.1038/342705a0 2531845 (Pubitemid 20001591)
4. M Oren 2003 Decision making by p53: life, death and cancer Cell Death 10 431 442 1:CAS:528:DC%2BD3sXjt1GjsLg%3D 10.1038/sj.cdd.4401183 (Pubitemid 36626355)
5. LA Donehower 2005 p53 guardian and suppressor of longevity? Exp Gerontol 40 7 9 1:CAS:528:DC%2BD2MXmtlelsw%3D%3D 10.1016/j.exger.2004.10.007 15664727 (Pubitemid 40138740)
6. S Wang-Gohrke TR Rebbeck W Besenfelder R Kreienberg IB Runnebaum 1998 p53 germline polymorphisms are associated with an increased risk for breast cancer in German women Anticancer Res 18 2095 2099 1:STN:280:DyaK1czkt1Cgug%3D%3D 9677474
7. EN Papadakis DN Dokianakis DA Spandidos 2000 p53 codon 72 polymorphisms as a risk factor in the development of breast cancer Mol Cell Bio Res Comm 3 389 392 1:CAS:528:DC%2BD3cXotlGiuro%3D 10.1006/mcbr.2000.0241
8. TG Kalemi AF Lambropoulos M Gueorguiev S Chrisafi KT Papazisis A Kotsis 2005 The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece Cancer Lett 222 57 65 1:CAS:528:DC%2BD2MXjtlans7s%3D 10.1016/j.canlet.2004.11.025 15837541 (Pubitemid 40544847)
9. A Själander R Birgander G Hallmans S Cajander P Lenner L Athlin G Beckman L Beckman 1996 p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 17 1313 1316 10.1093/carcin/17.6.1313 8681448 (Pubitemid 26196343)
10. M Akkiprik O Sonmez BM Gulluoglu HB Caglar H Kaya P Demirkalem U Abacioglu M Sengoz A Sav A Ozer 2009 Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer Pathol Oncol Res 15 359 368 1:CAS:528:DC%2BD1MXhsFCltrbK 10.1007/s12253-008-9129-6 19048399
11. AP Damin AP Frazzon DC Damin A Roehe V Hermes C Zettler CO Alexandre 2006 Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk Cancer Detect Prev 30 523 529 1:CAS:528:DC%2BD2sXhtlSnt7w%3D 10.1016/j.cdp.2006.09.007 17113725 (Pubitemid 44828290)
12. MN Aoki AHAC da Silva MK Amarante JL do Val Carneiro MH Fungaro MA Watanabe 2009 CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development Int J Mol Med 23 429 435 1:CAS:528:DC%2BD1MXjs1Khs7w%3D 19212663
13. C Baynes CS Healey KA Pooley S Scollen RN Luben DJ Thompson PD Pharoah DF Easton BA Ponder AM Dunning 2007 SEARCH breast cancer study: common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk Breast Cancer Res 9 2 R27 10.1186/bcr1669 17428325 (Pubitemid 350215160)
14. N Buyru H Tigli N Dalay 2003 P53 codon 72 polymorphism in breast cancer Oncol Rep 10 711 714 1:CAS:528:DC%2BD3sXjsVOltLg%3D 12684648
15. S Gochhait SI Bukhari N Bairwa S Vadhera K Darvishi M Raish P Gupta SA Husain RN Bamezai 2007 Implication of BRCA2-26G>A 5′ untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism Breast Cancer Res 9 R71 10.1186/bcr1780 17945002
16. LA Henríquez-Hernández A Murias-Rosales GA Hernández DLA Cabrera BN Díaz-Chico DSM Mori PL Fernández 2009 Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study Oncol Rep 22 1425 1433 10.3892/or-00000584 19885596
17. XE Huang N Hamajima N Katsuda K Matsuo K Hirose M Mizutani H Iwata S Miura J Xiang S Tokudome K Tajima 2003 Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer Breast Cancer 10 307 311 10.1007/BF02967650 14634508
18. S Katiyar BK Thelma NS Murthy S Hedau N Jain V Gopalkrishna SA Husain BC Das 2003 Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India Mol Cell Biochem 252 117 124 1:CAS:528:DC%2BD3sXmvFeqsro%3D 10.1023/A:1025546610920 14577584 (Pubitemid 37220740)
19. B Khadang MJ Fattahi A Talei AS Dehaghani A Ghaderi 2007 Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women Cancer Genet Cytogenet 173 38 42 1:CAS:528:DC%2BD2sXhtlCks78%3D 10.1016/j. cancergencyto.2006.09.010 17284368 (Pubitemid 46187296)
20. T Li ZM Lu M Guo QJ Wu KN Chen HP Xing Q Mei Y Ke 2002 p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China Cancer 95 2571 2576 1:CAS:528:DC%2BD38Xpslehsbc%3D 10.1002/cncr.11008 12467072 (Pubitemid 35424044)
21. I Mabrouk S Baccouche R El-Abed R Mokdad-Gargouri A Mosbah S Saïd J Daoud M Frikha R Jlidi A Gargouri 2003 No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients Ann N Y Acad Sci 1010 764 770 1:CAS:528:DC%2BD2cXisFeqtrY%3D 10.1196/annals.1299.137 15033824 (Pubitemid 38265078)
22. MK Schmidt S Reincke A Broeks LM Braaf FB Hogervorst RA Tollenaar N Johnson O Fletcher J Peto J Tommiska C Blomqvist HA Nevanlinna CS Healey AM Dunning PD Pharoah DF Easton T Dörk LJ Van't Veer 2007 Breast cancer association consortium: do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium Cancer Res 67 9584 9590 1:CAS:528:DC%2BD2sXhtFSnurjL 10.1158/0008-5472.CAN-07-0738 17909070 (Pubitemid 47535950)
23. BL Sprague A Trentham-Dietz M Garcia-Closas PA Newcomb L Titus-Ernstoff JM Hampton SJ Chanock JL Haines KM Egan 2007 Genetic variation in TP53 and risk of breast cancer in a population-based case control study Carcinogenesis 28 1680 1686 1:CAS:528:DC%2BD2sXpt1ehuro%3D 10.1093/carcin/bgm097 17449902 (Pubitemid 47289028)
24. J Tommiska H Eerola M Heinonen L Salonen M Kaare J Tallila A Ristimäki K von Smitten K Aittomäki P Heikkilä C Blomqvist H Nevanlinna 2005 Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival Clin Cancer Res 11 5098 5103 1:CAS:528:DC%2BD2MXmt12qtLk%3D 10.1158/1078-0432.CCR-05-0173 16033823 (Pubitemid 41003693)
25. S Wang-Gohrke H Becher R Kreienberg IB Runnebaum J Chang-Claude 2003 Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years Pharmacogenetics 12 269 272 10.1097/00008571-200204000-00012
26. A Weston CF Pan HB Ksieski S Wallenstein GS Berkowitz PI Tartter IJ Bleiweiss ST Brower RT Senie MS Wolff 1997 p53 haplotype determination in breast cancer Cancer Epidemiol Biomarkers Prev 6 105 112 1:CAS:528:DyaK2sXhs1Kht70%3D 9037561
27. W Zhang MJ Jin K Chen 2007 Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer Zhejiang Da Xue Xue Bao Yi Xue Ban 36 561 566 1:CAS:528:DC%2BD1cXhsFWksLzE 18067229
28. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
29. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
30. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
31. A Tobias 1999 Assessing the influence of a single study in the meta-analysis estimate Stata Tech Bull 8 15 17
32. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563
33. Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC (2010) Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0731-4